{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:10:36Z","timestamp":1775765436739,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.metabol.2013.09.007","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T09:16:18Z","timestamp":1382001378000},"page":"1830-1839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome"],"prefix":"10.1016","volume":"62","author":[{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Karmaniolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Chamberland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Nikolaidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antigoni","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Dionyssiou-Asteriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2013.09.007_bb0005","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"11","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2013.09.007_bb0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.04.014","article-title":"Epidemiology of myelodysplastic syndromes","volume":"125","author":"Ma","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2013.09.007_bb0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajh.23264","article-title":"Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management","volume":"87","author":"Garcia-Manero","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12185-012-1002-4","article-title":"Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes","volume":"95","author":"Tsushima","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0025","first-page":"603","article-title":"Risk factors for myelodysplastic syndromes: a case\u2013control study in Greece","volume":"13","author":"Dalamaga","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2013.09.007_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000120995","article-title":"Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case\u2013control study","volume":"73","author":"Dalamaga","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.metabol.2013.09.007_bb0035","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ejca.2008.04.015","article-title":"Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system","volume":"44","author":"Dalamaga","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.metabol.2013.09.007_bb0040","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/aje\/kwp074","article-title":"Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort","volume":"169","author":"Ma","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0045","first-page":"193","article-title":"Insulin resistance: the clinical spectrum","volume":"6","author":"Mantzoros","year":"1995","journal-title":"Adv Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.09.007_bb0050","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1210\/en.2011-0231","article-title":"Minireview: IGF, insulin, and cancer","volume":"152","author":"Gallagher","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2013.09.007_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2013.09.007_bb0065","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2003-030214","article-title":"Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies","volume":"88","author":"Gavrila","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.09.007_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.bjc.6602896","article-title":"Adiponectin in relation to childhood myeloblastic leukaemia","volume":"94","author":"Petridou","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2013.09.007_bb0075","doi-asserted-by":"crossref","first-page":"991S","DOI":"10.3945\/ajcn.2008.26788E","article-title":"Leptin in humans: lessons from translational research","volume":"89","author":"Bl\u00fcher","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2013.09.007_bb0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187221411799015372","article-title":"Fetuin-A: a multifunctional protein","volume":"5","author":"Mori","year":"2011","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1016\/j.metabol.2013.09.007_bb0085","doi-asserted-by":"crossref","first-page":"e1765","DOI":"10.1371\/journal.pone.0001765","article-title":"Fetuin-A induces cytokine expression and suppresses adiponectin production","volume":"3","author":"Hennige","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2013.09.007_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0095","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2013.09.007_bb0100","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/diabetes.51.7.2105","article-title":"Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans","volume":"51","author":"Chan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2013.09.007_bb0105","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.metabol.2011.11.015","article-title":"Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan","volume":"61","author":"Tseng","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.metabol.2013.01.014","article-title":"Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies","volume":"62","author":"Thakkar","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0115","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.metabol.2011.05.002","article-title":"Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study","volume":"60","author":"Buchs","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0120","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.metabol.2011.03.005","article-title":"Metabolic syndrome and pancreatic cancer risk: a case\u2013control study in Italy and meta-analysis","volume":"60","author":"Rosato","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.metabol.2010.12.002","article-title":"Insulin resistance: an independent risk factor for lung cancer?","volume":"60","author":"Petridou","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0130","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.metabol.2010.09.012","article-title":"Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort","volume":"60","author":"Baur","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2010.02.006","article-title":"Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients","volume":"60","author":"Park","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.metabol.2011.01.007","article-title":"Increased levels of serum glucose-dependent insulinotropic polypeptide as a novel risk factor for human colorectal adenoma","volume":"60","author":"Sasaki","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.metabol.2009.11.019","article-title":"Metabolic syndrome and risk of death from cancers of the digestive system","volume":"59","author":"Matthews","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0150","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cellsig.2010.11.003","article-title":"The \"thrifty\" gene encoding Ahsg\/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance","volume":"23","author":"Goustin","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2013.09.007_bb0155","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0160","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1210\/jc.2010-0148","article-title":"Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss","volume":"95","author":"Brix","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.09.007_bb0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes\u2014pathogenesis and clinical relevance","volume":"2","author":"Roden","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.09.007_bb0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0609.2005.00551.x","article-title":"Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis","volume":"75","author":"Stifter","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(01)00193-X","article-title":"In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome","volume":"26","author":"Flores-Figueroa","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.metabol.2013.09.007_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1023\/A:1014412013445","article-title":"Fetuin in human bone marrow: detection in foetal tissue and patients with mastocytosis","volume":"33","author":"Dziegielewska","year":"2001","journal-title":"Histochem J"},{"key":"10.1016\/j.metabol.2013.09.007_bb0185","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.2353\/ajpath.2010.100177","article-title":"Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer","volume":"177","author":"Guillory","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0190","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2013.09.007_bb0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yfrne.2010.06.002","article-title":"Leptin in human physiology and therapeutics","volume":"31","author":"Dardeno","year":"2010","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","article-title":"Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives","volume":"18","author":"Dalamaga","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2013.09.007_bb0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2013.09.007_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4093\/dmj.2012.36.3.181","article-title":"Leptin in relation to the lipodystrophy-associated metabolic syndrome","volume":"36","author":"Mantzoros","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2013.09.007_bb0215","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","article-title":"Leptin in human physiology and pathophysiology","volume":"301","author":"Mantzoros","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.09.007_bb0220","first-page":"575397","article-title":"Cellular signal transduction pathways by leptin in colorectal cancer tissue: preliminary results","volume":"2011","author":"Nowakowska-Zajdel","year":"2011","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.metabol.2013.09.007_bb0225","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood.V93.5.1668.405a15_1668_1676","article-title":"Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities","volume":"93","author":"Konopleva","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2013.09.007_bb0230","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/3810","article-title":"Associations between adipokines and obesity-related cancer","volume":"16","author":"Paz-Filho","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.metabol.2013.09.007_bb0235","first-page":"1451","article-title":"B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case\u2013control study in Greece","volume":"21","author":"Dalamaga","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2013.09.007_bb0240","first-page":"625","article-title":"Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case\u2013control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2013.09.007_bb0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2013.09.007_bb0250","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.metabol.2008.04.019","article-title":"Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus","volume":"57","author":"Mori","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.09.007_bb0255","doi-asserted-by":"crossref","first-page":"936906","DOI":"10.1155\/2008\/936906","article-title":"The development of INT131 as a selective PPARgamma modulator: approach to a safer insulin sensitizer","volume":"2008","author":"Higgins","year":"2008","journal-title":"PPAR Res"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:03:49Z","timestamp":1758427429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0026049513002916"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.09.007","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}